Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.
Teoxane issues competing buyout bid for Revance and its Botox rival
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS